301 related articles for article (PubMed ID: 15149845)
1. Rapid inactivation of alpha-1-proteinase inhibitor by neutrophil specific leukolysin/membrane-type matrix metalloproteinase 6.
Nie J; Pei D
Exp Cell Res; 2004 Jun; 296(2):145-50. PubMed ID: 15149845
[TBL] [Abstract][Full Text] [Related]
2. Neutrophil-derived serine proteinases enhance membrane type-1 matrix metalloproteinase-dependent tumor cell invasion.
Shamamian P; Pocock BJ; Schwartz JD; Monea S; Chuang N; Whiting D; Marcus SG; Galloway AC; Mignatti P
Surgery; 2000 Feb; 127(2):142-7. PubMed ID: 10686978
[TBL] [Abstract][Full Text] [Related]
3. Subcellular distribution and cytokine- and chemokine-regulated secretion of leukolysin/MT6-MMP/MMP-25 in neutrophils.
Kang T; Yi J; Guo A; Wang X; Overall CM; Jiang W; Elde R; Borregaard N; Pei D
J Biol Chem; 2001 Jun; 276(24):21960-8. PubMed ID: 11282999
[TBL] [Abstract][Full Text] [Related]
4. Direct activation of pro-matrix metalloproteinase-2 by leukolysin/membrane-type 6 matrix metalloproteinase/matrix metalloproteinase 25 at the asn(109)-Tyr bond.
Nie J; Pei D
Cancer Res; 2003 Oct; 63(20):6758-62. PubMed ID: 14583471
[TBL] [Abstract][Full Text] [Related]
5. Leukolysin/MMP25/MT6-MMP: a novel matrix metalloproteinase specifically expressed in the leukocyte lineage.
Pei D
Cell Res; 1999 Dec; 9(4):291-303. PubMed ID: 10628838
[TBL] [Abstract][Full Text] [Related]
6. Matrix metalloproteinase-26 is associated with estrogen-dependent malignancies and targets alpha1-antitrypsin serpin.
Li W; Savinov AY; Rozanov DV; Golubkov VS; Hedayat H; Postnova TI; Golubkova NV; Linli Y; Krajewski S; Strongin AY
Cancer Res; 2004 Dec; 64(23):8657-65. PubMed ID: 15574774
[TBL] [Abstract][Full Text] [Related]
7. Inactivation of alpha1-proteinase inhibitor as a broad screen for detecting proteolytic activities in unknown samples.
Nelson D; Potempa J; Travis J
Anal Biochem; 1998 Jul; 260(2):230-6. PubMed ID: 9657883
[TBL] [Abstract][Full Text] [Related]
8. Substrate specificity of Xenopus matrix metalloproteinase stromelysin-3.
Amano T; Fu L; Sahu S; Markey M; Shi YB
Int J Mol Med; 2004 Aug; 14(2):233-9. PubMed ID: 15254771
[TBL] [Abstract][Full Text] [Related]
9. Competition between elastase and related proteases from human neutrophil for binding to alpha1-protease inhibitor.
Korkmaz B; Poutrain P; Hazouard E; de Monte M; Attucci S; Gauthier FL
Am J Respir Cell Mol Biol; 2005 Jun; 32(6):553-9. PubMed ID: 15764720
[TBL] [Abstract][Full Text] [Related]
10. Comparative cleavage sites within the reactive-site loop of native and oxidized alpha1-proteinase inhibitor by selected bacterial proteinases.
Rapala-Kozik M; Potempa J; Nelson D; Kozik A; Travis J
Biol Chem; 1999 Oct; 380(10):1211-6. PubMed ID: 10595584
[TBL] [Abstract][Full Text] [Related]
11. Effect of polynucleotides on the inhibition of neutrophil elastase by mucus proteinase inhibitor and alpha 1-proteinase inhibitor.
Belorgey D; Bieth JG
Biochemistry; 1998 Nov; 37(46):16416-22. PubMed ID: 9819234
[TBL] [Abstract][Full Text] [Related]
12. Divergent effects of alpha1-antitrypsin on neutrophil activation, in vitro.
Janciauskiene S; Zelvyte I; Jansson L; Stevens T
Biochem Biophys Res Commun; 2004 Mar; 315(2):288-96. PubMed ID: 14766206
[TBL] [Abstract][Full Text] [Related]
13. Activation of progelatinase A (MMP-2) by neutrophil elastase, cathepsin G, and proteinase-3: a role for inflammatory cells in tumor invasion and angiogenesis.
Shamamian P; Schwartz JD; Pocock BJ; Monea S; Whiting D; Marcus SG; Mignatti P
J Cell Physiol; 2001 Nov; 189(2):197-206. PubMed ID: 11598905
[TBL] [Abstract][Full Text] [Related]
14. Neutrophil elastase cleaves laminin-332 (laminin-5) generating peptides that are chemotactic for neutrophils.
Mydel P; Shipley JM; Adair-Kirk TL; Kelley DG; Broekelmann TJ; Mecham RP; Senior RM
J Biol Chem; 2008 Apr; 283(15):9513-22. PubMed ID: 18178964
[TBL] [Abstract][Full Text] [Related]
15. Neutrophil elastase, proteinase 3 and cathepsin G: physicochemical properties, activity and physiopathological functions.
Korkmaz B; Moreau T; Gauthier F
Biochimie; 2008 Feb; 90(2):227-42. PubMed ID: 18021746
[TBL] [Abstract][Full Text] [Related]
16. Pathogenesis of COPD. Part I. The role of protease-antiprotease imbalance in emphysema.
Abboud RT; Vimalanathan S
Int J Tuberc Lung Dis; 2008 Apr; 12(4):361-7. PubMed ID: 18371259
[TBL] [Abstract][Full Text] [Related]
17. Mutants of plasminogen activator inhibitor-1 designed to inhibit neutrophil elastase and cathepsin G are more effective in vivo than their endogenous inhibitors.
Stefansson S; Yepes M; Gorlatova N; Day DE; Moore EG; Zabaleta A; McMahon GA; Lawrence DA
J Biol Chem; 2004 Jul; 279(29):29981-7. PubMed ID: 15131125
[TBL] [Abstract][Full Text] [Related]
18. Highly potent irreversible inhibitors of neutrophil elastase generated by selection from a randomized DNA-valine phosphonate library.
Charlton J; Kirschenheuter GP; Smith D
Biochemistry; 1997 Mar; 36(10):3018-26. PubMed ID: 9062133
[TBL] [Abstract][Full Text] [Related]
19. Amino acid-derived phthalimide and saccharin derivatives as inhibitors of human leukocyte elastase, cathepsin G, and proteinase 3.
Groutas WC; Chong LS; Venkataraman R; Kuang R; Epp JB; Houser-Archield N; Huang H; Hoidal JR
Arch Biochem Biophys; 1996 Aug; 332(2):335-40. PubMed ID: 8806743
[TBL] [Abstract][Full Text] [Related]
20. Regulation of cystatin C activity by serine proteinases.
Abrahamson M; Buttle DJ; Mason RW; Hansson H; Grubb A; Lilja H; Ohlsson K
Biomed Biochim Acta; 1991; 50(4-6):587-93. PubMed ID: 1801727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
